Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ectodysplasin-A receptor-associated adapter protein (EDARADD) is an intracellular signaling adaptor containing a death domain, which couples the ectodysplasin-A receptor (EDAR) to downstream pathways, notably the NF-κB transcription factor cascade[1][3][4]. EDARADD is essential for interpreting signals between embryonic ectoderm and mesoderm, thus regulating development and morphogenesis of structures such as hair follicles, teeth, skin, and sweat glands[1][3]. Mutations in EDARADD disrupt protein-protein interactions necessary for normal signaling, causing various forms of ectodermal dysplasia, primarily hypohidrotic ectodermal dysplasia, characterized by defective hair, teeth, and sweat gland formation[1][4]. EDARADD interacts directly with EDAR, and recruits effectors like TRAF6 and TAB2, activating the IκB kinase complex and promoting cell-specific gene expression during organogenesis[3][4]. No approved drugs currently target EDARADD; its biological role makes it principally a molecular and diagnostic target for genetic disorders of ectodermal differentiation.
no approved drugs target this adapter protein directly; potential mechanism if developed: modulation of EDAR-NF-κB signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ectodysplasin-A receptor-associated adapter protein (EDARADD).